Michael Rauh, MSc, PhD, MD
SPECIALTY AND TITLE
Attending Hematopathologist and Associate Professor
Kingston Health Sciences Centre
AREA OF RESEARCH
The focus of Dr. Rauh’s research program is the genetic and immune origins of myeloid blood cancers. This includes the common, age-related, pre-cancerous conditional called clonal hematopoiesis (CHIP), and the impacts of myeloid immune cells carrying CHIP mutations on the risk of heart, lung, kidney, neurodegenerative and infectious diseases. By understanding how mutant clones manipulate and respond to the immune environment, his group is discovering novel biomarkers and treatment targets. Applying this knowledge, the goal is to provide more personalized diagnosis and care and, ultimately, prevention of myeloid cancers and co-morbid diseases among the estimated 1 million Canadians harboring CHIP.
MAJOR CONTRIBUTIONS TO SCIENCE AND/OR HEALTH CARE DELIVER
Dr. Rauh is an Associate Professor in the Department of Pathology and Molecular Medicine in Queen’s Faculty of Health Sciences. Dr. Rauh’s accomplishments have made major impacts in uncovering the genetic and immune origins of myeloid blood cancers, and in the application of precision genetic testing to advance personalized molecular medicine at Kingston Health Sciences Centre (KHSC), in Ontario and internationally. He has been recognized internationally by the American Society of Hematology (ASH) and European Hematology Agency, and as a Celgene Future Leader in Hematology, nationally by the Canadian Association of Pathologists as a Junior Scientist Award winner, and in Ontario by the Ontario Institute of Cancer Research (OICR) as a Transformative Pathology Research Scholar. He has served as a consultant for the Pediatric Oncology Group of Ontario and Ontario Health/Cancer Care Ontario.